Stepan Company, a supplier of surfactants used in cleaning products, announced a 2.5% dividend increase for the 59th consecutive year, underscoring its long-term financial stability. Despite being relatively unknown and smaller in size, Stepan has maintained steady revenue and profit growth, even through economic downturns like 2009 and 2020. The company benefits from strong customer loyalty due to the complexity of switching ingredients in cleaning formulas and has managed to raise prices to offset rising raw material costs. Investors can expect continued dividend growth, supported by steady cash flow and ongoing cost-saving initiatives, though raw material price volatility remains a risk.
Stepan Company's 2.5% dividend increase marks its 59th consecutive year of growth, highlighting its financial resilience. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 28, 2026 19:42 WIB: out of 83 priced US stocks, 28 rose and 51 fell. Notable movers include ALM at USD 9.72 with a 1-day change of +1.67% and 100% buy order activity, IFF at USD 91.81 down 1.50%, and CRH at USD 87.00 up 1.43%.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
